lisocabtagene maraleucel,ibrutinib,venetoclax
BMS,Roche,Abbvie
['liso-cel', 'cll']
liso-cel leads to rapid responses, high undetectable mrd rates in relapsed/refractory cll/sll #asco23 #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.